Alector Inc (ALEC)
5.25
+0.03
(+0.57%)
USD |
NASDAQ |
May 10, 16:00
5.25
0.00 (0.00%)
After-Hours: 19:31
Alector Cash from Investing (TTM): 1.452M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.452M |
December 31, 2023 | 101.92M |
September 30, 2023 | 102.23M |
June 30, 2023 | 145.80M |
March 31, 2023 | -58.21M |
December 31, 2022 | -159.01M |
September 30, 2022 | -324.15M |
June 30, 2022 | -453.73M |
March 31, 2022 | -171.32M |
December 31, 2021 | -49.66M |
September 30, 2021 | 108.64M |
Date | Value |
---|---|
June 30, 2021 | 210.71M |
March 31, 2021 | 129.37M |
December 31, 2020 | -105.05M |
September 30, 2020 | -86.55M |
June 30, 2020 | -73.65M |
March 31, 2020 | -22.48M |
December 31, 2019 | -48.87M |
September 30, 2019 | -36.47M |
June 30, 2019 | -129.32M |
March 31, 2019 | -195.87M |
December 31, 2018 | -224.12M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-453.73M
Minimum
Jun 2022
210.71M
Maximum
Jun 2021
-45.92M
Average
-49.27M
Median
Cash from Investing (TTM) Benchmarks
AbbVie Inc | -11.10B |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |